share_log

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%), etc.

Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等

SEC announcement ·  02/15 16:23
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息